Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2026-01-08 00:00:00 ET · period of report 2026-01-06 · accession 0001193125-26-008023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-08 | 2026-01-06 | CORT | Guyer William | Chief Development Off | M - OptEx | $21.65 | +20.0K | 21.2K | +1,619% | +$433.0K |
| DT | 2026-01-08 | 2026-01-06 | CORT | Guyer William | Chief Development Off | S - Sale+OE | $35.18 | -20.0K | 1,235 | -94% | -$703.6K |
| DT | 2026-01-08 | 2026-01-06 | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -20.0K | 250.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-06 | M | A | 20,000 | $21.65 | 21,235 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-06 | S | D | 20,000 | $35.18 | 1,235 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $34.96 to $35.50 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Derivative | Stock option (right to buy) | 2026-01-06 | M | D | 20,000 | $0.00 | 250,000 | D | $21.65 · — to 2031-09-01 | 20,000 Common Stock | (F3) Fully exercisable. |